Ping Huang, Jia-huan Huang, Jia-huan Huang, Ya-bing Zheng, Wen-ming Cao, Xi-ying Shao, . . . Zhan-hong Chen. (2022). Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy. Frontiers Media S.A..
Chicago Style (17th ed.) CitationPing Huang, et al. Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationPing Huang, et al. Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.